insights_auto
Why is ONCY up 2,31%?
Dive Deeperchevron_right
ONCY:NASDAQ
Oncolytics Biotech Inc
0,56 US$
arrow_upward
+2,31%(+0,013) 1D
0,55 US$
arrow_downward
-1,69% (-0,0094)bedtimeAfter hours
Closed: 9 ოქტ, 16:00:00 GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for ONCY...
Open
0,55 US$
High
0,57 US$
Low
0,52 US$
Mkt. cap
73,63 მლნ.
Avg. vol.
1,05 მლნ.
Volume
1,46 მლნ.
52-wk high
1,32 US$
52-wk low
0,52 US$
Beta
1,15
Shares outstanding
127,51 მლნ.
No. of employees
29
Open
0,55 US$
High
0,57 US$
Low
0,52 US$
Mkt. cap
73,63 მლნ.
Avg. vol.
1,05 მლნ.
Volume
1,46 მლნ.
52-wk high
1,32 US$
52-wk low
0,52 US$
Beta
1,15
Shares outstanding
127,51 მლნ.
No. of employees
29
News stories
From web sources and news partners
TradingView
·
1 საათის წინ
Retension Pharmaceuticals, Clinical-Stage Developer of Hypertension Therapies, Files for Nasdaq Capital Market IPO
TheStreet Pro
·
25 წუთის წინ
A Broad Friday Rally Takes the S&P 500 Just Below Record Highs
Yahoo Finance
·
1 საათის წინ
Ruanyun Edai Technology Inc. Receives Nasdaq Minimum Bid Price Deficiency Notice
Nasdaq
·
9 საათის წინ
WISeSat.Space Holdings Corp. Rings the Opening Bell
Profile
Oncolytics Biotech Inc. is a biotech company headquartered in San Diego, California, that is developing an intravenously delivered immuno-oncolytic virus called pelareorep for the treatment of solid tumors and hematological malignancies. Pelareorep is a non-pathogenic, proprietary isolate of the unmodified reovirus that induces selective tumor lysis and promotes an inflamed tumor phenotype through innate and adaptive immune responses. Wikipedia
About Oncolytics Biotech Inc